Navigation Links
Oracle chairman Jeff Henley makes $50 million gift to UC Santa Barbara
Date:5/14/2012

he near-term benefits of what we produce which includes our students as well as intellectual property and technology," said Rod Alferness, Dean of Engineering at UCSB. "The Henleys' vital support especially critical given state-funding restrictions gives us the ability to do both of those things by creating extraordinary research opportunities for our faculty and students alike."

Longtime benefactors of the campus, the Henleys' myriad investments in UC Santa Barbara include the Jeff Henley Endowed Chair in Economics, currently held by Nobel Laureate Finn Kydland. They have also furnished significant support for the College of Engineering and many other areas across campus, including intercollegiate athletics. Judy Henley provided the conceptual design for the Henley Gate. Jeff Henley chairs the IEE's Directors Council and Global Advisory Board, and is a member of the College of Engineering Dean's Cabinet.

Jeff Henley is Chairman of the Board of Oracle, which engineers hardware and software to work together in the cloud and in your data center, based in Redwood Shores, Calif. He was Oracle's chief financial officer from 1991 to 2004.


'/>"/>

Contact: Shelly Leachman
shelly.leachman@ia.ucsb.edu
805-893-8726
University of California - Santa Barbara
Source:Eurekalert  

Page: 1 2 3 4

Related biology technology :

1. C3i Inc to Provide Full-Service Technology Support and Oracle Clinical, Oracle Remote Data Capture Business Process Outsourcing to XBiotech, Inc
2. Intrasphere Technologies Launches SafetyXpress(TM) for Oracle(R) Argus Safety
3. Intrasphere Technologies Achieves Oracle PartnerNetwork Specialization for Oracle Argus Safety Suite
4. C3i and Bristol-Myers Squibb to Discuss the Effects of Oracle Clinical 4.5.3 Zero Footprint on Support Services at the Oracle Health Sciences User Group Conference
5. Industry Leaders from Blue Coat, Oracle, Polycom, Siemens and Taleo Headline SiriusDecisions Sales and Marketing Summit 2010
6. Sigma-Aldrich Enters Exclusive Supply Agreement With Gene Oracle to Leverage Its Unique GeneIOS Gene Synthesis Platform
7. DAZ Systems, Inc. Showcases Oracle Business Accelerator for Agile Product Lifecycle Management
8. Life Sciences Organizations Choose Oracle to Accelerate and Simplify Clinical Trial Data Collection
9. Satyam Partners with Oracle to Provide Clinical Development Applications
10. China Biologic Products Names Chairman David Gao to Additional Post of CEO
11. Synthetic Biologics Appoints Jeffrey J. Kraws as Independent Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Oracle chairman Jeff Henley makes $50 million gift to UC Santa Barbara
(Date:7/30/2015)... Marshall, MN (PRWEB) , ... July 31, 2015 , ... ... Ralco Enrichment Center at the Lyon County Fair to be held August 5-9 in ... more about where their meals come from and how agriculture impacts their daily lives. ...
(Date:7/30/2015)... July 30, 2015 According to ... (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, ... Preclinical, Clinical Trial), by End Users - Global Forecast ... expected to reach USD 2,107.99 million by 2020 from ... 15.29%. Browse more than ...
(Date:7/30/2015)... July 30, 2015 Ascendis Pharma A/S ... applies its innovative TransCon technology to address significant ... from a six-month Phase 2 study to evaluate ... Hormone in 53 treatment-naïve, pre-pubertal children with growth ... extremely pleased with the top-line results from our ...
(Date:7/29/2015)... 30, 2015 Sanofi, a ... the second quarter of 2015. CEO Olivier ... its performance in different businesses. Watch ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered in the ... - Performance drivers - Diabetes ...
Breaking Biology Technology:Ralco Announces Primary Sponsorship of Ralco Enrichment Center at Lyon County Fair 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
... PALO ALTO, Calif., Oct. 24 Vivo Ventures, a ... that,James Huang will join the firm as an Executive ... Mr. Huang will,work with Vivo,s portfolio companies while enhancing ... James coming on board and what he will be ...
... 24 Cell Therapeutics,Inc. (CTI) (Nasdaq and ... 19th annual AACR-NCI-EORTC Symposium show its bis-platinate ... to currently,marketed platinum agents carboplatin, cisplatin and ... in late 2008. "Bis-platinates represent a ...
... is available in German . , Hydrogen fuel ... have so far suffered from being insufficiently competitive. At the ... Strasser has now developed a new class of electrocatalyst that ... active phase of the catalyst consists of nanoparticles with a ...
Cached Biology Technology:Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence 2First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs 2First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs 3Platinum-rich shell, platinum-poor core 2
(Date:7/9/2015)... , July 07, 2015 ... announced the addition of the "Biometrics for ... Forecasts 2015-2020" report to their offering. ... major contributor to this growth and the forecast ... billion in revenue for companies involved in delivering ...
(Date:7/8/2015)... YORK , July 8, 2015  BD (Becton, ... BD & Guidepoint Mentor, a new program ... Guidepoint,s expert network services. BD is ... to improve healthcare delivery and outcomes and, with the ... entrepreneur will be able to directly engage with industry ...
(Date:7/7/2015)... VIEW, Calif. , July 7, 2015 /PRNewswire/ ... biometrics market, Frost & Sullivan recognizes Credence ID, ... Sullivan Entrepreneurial Company of the Year Award. ... suite to aid in its mission of offering ... under-recognized populations globally. As Credence ID was formed ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... cold is not only uncomfortable, it can be deadlycausing ... years now, scientists have understood the molecular mechanisms that ... high temperatures that directly trigger heat sensor proteins known ... is how animals sense very small temperature differences in ...
... Detecting deadly fumes in subways, toxic gases ... is becoming easier and more efficient with a ... improve the technique,s sensitivity, scientists must design better ... them. , Researchers at the University of Illinois, ...
... mothers need to rebuild muscles and strengthen their stamina. Now ... that recovery during a pilot study at Case Western Reserve ... in bed is not a benign kind of thing," says ... She has been studying the effects of bed rest ...
Cached Biology News:Summer heat too hot for you? What is comfortable? 2Summer heat too hot for you? What is comfortable? 3Killer pulses help characterize special surfaces 2Ante-partum bed rest moms get active in Case Western Reserve University study 2
Phospho-Btk (Tyr223) Antibody...
Rad51B...
p27 rabbit polyclonal antibody...
This antibody detects an ~25 kDa band, corresponding to the expected molecular mass of Rab3A, on immunoblots. The antibody specificity is confirmed in peptide inhibition immunoblotting studies....
Biology Products: